Premium
Can prostate biopsies affect erectile function?
Author(s) -
Chrisofos M.,
Papatsoris A. G.,
Dellis A.,
Varkarakis I. M.,
Skolarikos A.,
Deliveliotis C.
Publication year - 2006
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/j.1439-0272.2006.00714.x
Subject(s) - medicine , erectile dysfunction , concomitant , prostate biopsy , prostate , erectile function , biopsy , urology , international prostate symptom score , lower urinary tract symptoms , cancer
Summary The impact of transrectal ultrasound (TRUS)‐guided prostate biopsies on erectile function was prospectively studied. Forty‐six men (median age: 67.51 years) who underwent TRUS‐guided prostate biopsies completed the International Index of Erectile Function (IIEF)‐5 questionnaire at the day of the biopsy, 1 and 3 months later. Erectile dysfunction (ED) severity was classified into five categories. Concomitant ED‐related systemic diseases and/or medications that could affect erectile function were also recorded. The paired t ‐test was used for statistical analysis. The median IIEF‐5 score was 15.91 prior to biopsies, while 1 and 3 months after, the median IIEF‐5 score was 14.33 and 14.81 respectively ( P > 0.05). Prior to prostate biopsies, ED was reported by 38 patients (82.60%): mild ED in 39.13%, mild to moderate in 19.56%, moderate in 15.21% and severe ED in 8.69%. Concomitant ED‐related systemic diseases and/or medications were recorded in 28 patients (60.86%). One month after, ED was revealed in 42 patients (91.30%): mild ED in 26.08%, mild to moderate in 30.43%, moderate in 19.56%, and severe ED in 15.21%. Three months post‐biopsy, ED was reported by 41 patients (89.13): mild ED in 21.73%, mild to moderate in 28.26%, moderate in 21.73%, and severe ED in 17.39%. Overall, three and two patients (6.52% and 4.34%) had prostate biopsy attributed ED (i.e. without concomitant ED‐related disease or medication) 1 and 3 months after prostate biopsies. TRUS‐guided prostate biopsies did not induce ED in a statistically significant manner. Evaluating potency at referral for TRUS‐guided prostate biopsies is advisable.